THEMISMED.BOTHEMISMED.BOBSE
Loading
Year-over-year SG&A expense growth
Latest
0.00%
↓ 100% vs avg
Percentile
P49
Within normal range
Average
1.93%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 0.00% |
| Q2 2025 | -100.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | -100.00% |
| Q3 2024 | 9.43% |
| Q2 2024 | -22.31% |
| Q1 2024 | 42.04% |
| Q4 2023 | -8.28% |
| Q3 2023 | 19.15% |
| Q2 2023 | 6.48% |
| Q1 2023 | 2.75% |
| Q4 2022 | -12.00% |
| Q3 2022 | -5.29% |
| Q2 2022 | 12.56% |
| Q1 2022 | -2.78% |
| Q4 2021 | -9.65% |
| Q3 2021 | 44.64% |
| Q2 2021 | 6.44% |
| Q1 2021 | 83.79% |
| Q4 2020 | 5.47% |
| Q3 2020 | -6.14% |
| Q2 2020 | -35.84% |
| Q1 2020 | 42.35% |
| Q4 2019 | -1.34% |
| Q3 2019 | 4.21% |
| Q2 2019 | -42.52% |
| Q1 2019 | 66.91% |
| Q4 2018 | -4.29% |
| Q3 2018 | -3.26% |
| Q2 2018 | -43.67% |
| Q1 2018 | 83.18% |
| Q4 2017 | 7.48% |
| Q3 2017 | 1.53% |
| Q2 2017 | -30.54% |
| Q1 2017 | 45.60% |
| Q4 2016 | -3.70% |
| Q3 2016 | -1.72% |
| Q2 2016 | -17.04% |
| Q1 2016 | 43.59% |